Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results

Metro Treatment of Texas LP located in San Antonio, TX, offers outpatient detox and substance abuse therapy for both adults and young adults. The center delivers outpatient treatments involving methadone/buprenorphine or naltrexone, employing evidence-based methods like cognitive behavioral therapy, anger management, and brief interventions. This facility is dedicated to helping active military service members, individuals who have faced intimate partner violence, domestic violence, and survivors of sexual abuse. Customized programs are designed for both male and female clients. Committed to high-quality care and specialized assistance, this center strives to lead individuals towards sustainable recovery and enhanced well-being.

Metro Treatment of Texas LP, located in San Antonio, TX, provides comprehensive outpatient services for individuals struggling with substance use disorders and co-occurring mental health conditions. Their approach encompasses adults, young adults, and children, addressing a range of needs from general substance use to serious mental health illnesses and emotional disturbances. The center employs evidence-based practices such as cognitive behavioral therapy, anger management techniques, and brief intervention strategies to craft personalized treatment plans. Specialized programs are available for adult men and women, ensuring focused support. At Metro Treatment of Texas LP, client well-being is paramount, with medically supervised outpatient treatments including methadone, buprenorphine, or naltrexone available to all eligible individuals.

MetroHealth, located in Cleveland, OH, specializes in tailored substance use treatment programs designed for both adults and young adults. The center offers a variety of services, including intensive outpatient programs, standard outpatient care, and options for methadone, buprenorphine, or naltrexone treatments. Emphasizing cognitive behavioral therapy, the Matrix Model, and motivational interviewing, MetroHealth crafts a unique recovery plan for each individual, ensuring that the treatment is personalized. The center's strong focus on customized care distinguishes it, serving both male and female clients alike. If you are looking for thorough addiction treatment delivered with compassion and expertise, MetroHealth is committed to aiding you on your path to sustained sobriety.

Metro Treatment of Maine LP, located in Rockland, ME, provides an extensive range of outpatient services for those dealing with substance use disorders. This center administers outpatient treatment options including methadone and buprenorphine or naltrexone therapies, along with standard outpatient programs. It employs various therapeutic methods, such as brief interventions, cognitive behavioral therapy, and motivational incentives. The facility also features specialized programs designed for adult men and women, as well as for individuals who have faced trauma, allowing it to address the needs of a wide array of patients. Catering to both adult and young adult clients of all genders, Metro Treatment of Maine LP is dedicated to offering exceptional care and guidance throughout the recovery process.

Metro Treatment of New Hampshire, situated in Manchester, NH, provides outpatient care for substance use issues, featuring programs that include outpatient methadone/buprenorphine or naltrexone therapies. The center employs evidence-based methods such as cognitive behavioral therapy, motivational interviewing, and strategies for preventing relapse. With tailored programs for adult males, adult females, and individuals facing both mental health and substance use challenges, this facility serves a wide variety of clients. By offering quality support to adults and young adults of all genders, Metro Treatment of New Hampshire aims to assist individuals in their recovery process in a nurturing setting.

Metropolitan Rehabilitation Clinics in Oak Park, MI, provides an extensive selection of outpatient services aimed at those needing detoxification, treatment for substance use disorders, and assistance for co-occurring mental health issues. This center features outpatient detoxification, methadone and buprenorphine therapies, and dedicated programs for both adults and young adults facing challenges related to intimate partner violence. Utilizing diverse treatment methods such as 12-step facilitation and anger management, the facility serves clients of all genders. Metropolitan Rehabilitation Clinics emphasizes high-quality care and personalized brief interventions designed to meet the unique needs of each individual.

Metro Treatment of Utah LP, located in Woods Cross, UT, focuses on outpatient substance abuse services, particularly methadone, buprenorphine, and naltrexone-assisted treatment. Their approach includes brief interventions, motivational enhancement, and relapse avoidance techniques. The facility offers distinct programs for active military members, adult males, and adult females. Serving a broad demographic of adults and young adults, Metro Treatment of Utah LP emphasizes individualized care using scientifically supported methods. For those in need of complete addiction recovery support, this establishment offers a nurturing and successful setting.

Metro Treatment of Minnesota LP in Burnsville, MN, delivers comprehensive outpatient substance use disorder services. Their offerings include medication-assisted treatment utilizing methadone, buprenorphine, or naltrexone. The center emphasizes evidence-based therapeutic modalities such as cognitive behavioral therapy, motivational interviewing, and relapse prevention strategies. Tailored programming is available for adult men and women, and they cater to both adult and young adult populations. Metro Treatment of Minnesota LP is committed to providing high-quality, individualized care within a supportive setting, guiding each person toward sustained recovery. For those pursuing effective, personalized addiction treatment, this center is devoted to fostering long-term sobriety.

Metro Treatment of Kentucky LP, located in Covington, KY, specializes in outpatient programs designed for individuals struggling with substance use, including both adults and young adults. The center caters to the unique needs of adult men and women, along with clients who have faced intimate partner violence, creating a nurturing and secure atmosphere for recovery. The treatment methods employed encompass anger management, brief intervention strategies, and cognitive behavioral therapy, all aiming for a comprehensive healing experience. Individuals can receive either outpatient methadone/buprenorphine or naltrexone treatments, in addition to standard outpatient services, ensuring that they receive compassionate and research-based care. At Metro Treatment of Kentucky LP, the focus is on delivering high-quality, personalized support to assist each client on their path to recovery.

Methadone and buprenorphine are provided on an outpatient and intensive outpatient basis at Savannah Treatment Center in Savannah, Georgia, part of Metro Treatment of Georgia. Programs serve pregnant and postpartum women, adult men and women, and seniors. Medicare, Medicaid, TRICARE, and SAMHSA block grants are accepted.

The Metropolitan Center for Mental Health in New York City offers outpatient treatment for substance use and co-occurring serious mental illness, serving adolescents through seniors. Buprenorphine and naltrexone are used in treatment, with programs for trauma survivors. Medicare, Medicaid, payment assistance, and a sliding fee scale are available.

Outpatient and intensive outpatient substance use treatment at the Palos Hills Center in Palos Hills, Illinois. Buprenorphine is used for opioid use disorder, and programs serve young adults, women, men, and clients with co-occurring disorders. Medicare, Medicaid, private insurance, and sliding fees are accepted, with sign language services available.

The Merrionette Park Center in Alsip, Illinois, provides outpatient and intensive outpatient substance use treatment, with buprenorphine used for opioid use disorder. Young adults, women, men, and clients with co-occurring mental health conditions are served. Medicare, Medicaid, private insurance, sliding fees, and sign language services are available.

Metro Treatment of Maine LP in Bangor, ME, provides outpatient services for substance use disorders, including medication-assisted treatment with methadone, buprenorphine, or naltrexone. Their therapeutic interventions encompass anger management, brief intervention, and cognitive behavioral therapy, ensuring personalized care plans. The center supports adult men and women, including survivors of intimate partner or domestic violence. Catering to both adults and young adults of all genders, Metro Treatment of Maine LP emphasizes individualized recovery journeys. Known for its dedication to high-quality care and specialized programs, it is a reliable resource for comprehensive addiction treatment.

Metro Treatment of Minnesota LP in Saint Paul, MN, provides accessible outpatient addiction care, featuring medication-assisted treatment options like methadone, buprenorphine, and naltrexone. Their therapeutic approach centers on proven methods such as cognitive behavioral therapy, motivational interviewing, and strategies for preventing relapse. This center offers specialized support for adult men and women, serving a diverse population of adults and young adults, encompassing both male and female clients. By prioritizing personalized treatment strategies and employing scientifically validated techniques, Metro Treatment of Minnesota LP is dedicated to delivering effective recovery services.

Metro Treatment of Utah LP in Saint George, UT, provides outpatient detoxification and treatment for substance use disorders aimed at both adults and young adults. The center is dedicated to tailored care, employing techniques such as anger management, cognitive behavioral therapy, and motivational incentives through contingency management. Prioritizing high-quality treatment, this facility serves both men and women in their journey towards recovery from addiction. Whether individuals are in need of detoxification services or require ongoing medication-assisted treatment options like methadone, buprenorphine, or naltrexone, the center is committed to offering extensive support for those aiming to achieve sobriety.

Situated in Arabi, LA, the Metropolitan Human Services District provides focused treatment for adults grappling with substance use issues alongside mental health challenges, as well as support for children facing serious emotional difficulties. Their range of services encompasses intensive outpatient care, standard outpatient support, and medication-assisted treatment with methadone, buprenorphine, or naltrexone. By employing evidence-supported methodologies such as cognitive behavioral therapy, contingency management, and the Matrix Model, this center delivers customized care for adolescents, adults, and older adults. The Metropolitan Human Services District prioritizes personalized treatment strategies and offers gender-specific programs for both men and women, ensuring comprehensive and effective support for sustained recovery.

Situated in Sykesville, MD, Metwork Health Services Inc offers extensive outpatient programs for substance use rehabilitation. This center focuses on treatments involving methadone, buprenorphine, or naltrexone. It incorporates methods such as 12-step facilitation, anger management, and brief intervention strategies. Emphasizing personalized treatment, the facility serves adult men and women, including those who have been affected by intimate partner or domestic violence. Catering to both adults and young adults, Metwork Health Services Inc is dedicated to delivering high-quality care and customized assistance to individuals in need of efficient addiction treatment solutions.

Located in Miami, FL, Miami Dade CAHSD offers extensive treatment services for individuals dealing with substance use issues. The center provides a variety of recovery options, including long-term residential care, outpatient support, and day programs, with a focus on 12-step methods, anger management, and cognitive behavioral techniques. Special programs are designed for adult men, adult women, and individuals who have faced trauma. Emphasizing personalized care, this facility customizes its approach to address each client's unique challenges. Serving both genders, Miami Dade CAHSD fosters a welcoming and supportive atmosphere for those on the path to overcoming addiction and reclaiming their lives.

Miami Dade Community Services Inc, located in Miami, FL, provides a variety of evidence-based rehabilitation programs aimed at addressing substance use disorders and associated mental health challenges in both adults and children. Their offerings include intensive outpatient services, outpatient care, and day treatment, which integrate elements such as 12-step support, anger management, and concise therapeutic interventions. The center has tailored programs for active military members as well as specific groups for adult men and women, ensuring that it meets the needs of a wide range of individuals. Catering to clients across all genders, this facility emphasizes personalized treatment to facilitate healing and recovery. Miami Dade Community Services Inc remains a reliable option for those in search of comprehensive and effective rehabilitation solutions.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.